Where is Rosabella Moringa sourced and how are its supply chains structured?

Checked on January 15, 2026
Disclaimer: Factually can make mistakes. Please verify important information or breaking news. Learn more.

Executive summary

Rosabella presents its Moringa as “passionately grown, ethically sourced” and manufactured in a New Jersey cGMP facility, but public reporting yields conflicting supplier claims and sparse traceability details—meaning the brand’s packaging and marketing point to U.S. manufacturing while third‑party listings and industry marketplace data show China and India as likely nodes in the product’s upstream supply chain [1] [2] [3] [4] [5]. A full, verifiable map from farm to bottle is not available in the provided reporting, so the most accurate conclusion is that Rosabella’s supply chain is multi‑jurisdictional and opaque in publicly available sources [1] [4].

1. Where the company says the product comes from—and what that implies

Rosabella’s retail pages claim the Moringa powder is “passionately grown, ethically sourced” and emphasize that supplements are manufactured in a New Jersey cGMP‑certified facility after “rigorous quality inspections,” which positions the brand as selling a U.S.‑made, quality‑controlled finished product [1] [2] [3]. The company’s contact information also lists Ambrosia Brands LLC in Cheyenne, Wyoming as a corporate address, reinforcing a U.S. business front for marketing and customer service [6]. Those assertions are typical marketing signals designed to reassure consumers about quality and regulatory compliance, but they do not by themselves document raw‑material origins or independent testing results [2] [3] [6].

2. Third‑party supplier claims that complicate the picture

At least one Chinese contract manufacturer—Xi’an Ebos Biotech—lists a “Rosabella Moringa Capsule” among its offerings, asserting the company manufactures the capsules in China, which directly challenges the simple “made in USA” narrative for finished goods or suggests parallel/contract production offshore [4]. Wholesale and B2B listings further muddy provenance: marketplace pages tie Rosabella to U.S. wholesale distribution and list Moringa origins variably—some moringa powders on those platforms are labeled with Indian origin—indicating that raw Moringa leaf powder often flows from India while capsules or finished blends may be assembled elsewhere [7] [5].

3. How the supply chain appears structured from available signals

Synthesizing the company’s marketing with third‑party supplier pages and industry marketplace data suggests a common multi‑tier model: raw Moringa leaf powder is likely sourced from global suppliers (India is a known large producer), the powder may be purchased or blended by brand owners, and finished capsules are either manufactured domestically in a U.S. cGMP facility or contracted to overseas manufacturers such as Xi’an Ebos Biotech depending on volume, cost, or private‑label arrangements [5] [1] [4] [2]. Retail and wholesale listings show Rosabella sold through its own site and through retailers like Target and wholesale platforms, implying downstream logistics through U.S. distribution even when upstream inputs cross borders [8] [7].

4. Gaps, credibility issues, and competing narratives

Public sources do not supply batch‑level certificates of analysis, supplier contracts, or farm certifications that would definitively pin down country‑of‑origin for the leaf powder used in specific Rosabella lots; the brand’s marketing statements therefore function as claims rather than independently documented facts [1] [2]. The presence of a Chinese manufacturer listing the product and marketplace data showing India as a common origin raises plausible alternative explanations—domestic final assembly of imported powders, parallel manufacturing runs in China, or private‑label relationships—but none of those scenarios is uniquely corroborated by the material provided [4] [5]. Independent reviewers and catalog pages offer product scores and notes about testing benchmarks, but those sources indicate mixed consumer and quality signals rather than chain‑of‑custody proof [9] [7].

5. What consumers and investigators should look for next

To move from plausible structure to verified chain of custody requires documentary evidence not present in these sources: supplier certificates of origin, third‑party lab analyses tied to lot numbers, or a transparency statement from Rosabella naming upstream growers/processors—items the public pages do not provide but that would resolve whether the Moringa leaf is sourced from India, processed in China, and finished in the U.S., or follows a different path [1] [4] [5]. Until such documents are published, the defensible reporting line is that Rosabella markets a U.S.‑branded finished supplement while credible external listings show significant international involvement in manufacturing and raw‑material supply [2] [4] [7].

Want to dive deeper?
What documentation would conclusively prove the country of origin for a supplement’s botanical ingredient?
Which third‑party labs provide lot‑specific certificates of analysis for Moringa supplements and how to interpret them?
How do private‑label supplement supply chains typically use Chinese contract manufacturers and Indian raw‑material suppliers?